Correction: Novel protein-based prognostic signature linked to immunotherapeutic efficiency in ovarian cancer

Correction: Novel protein-based prognostic signature linked to immunotherapeutic efficiency in ovarian cancer

Saved in:

Bibliographic Details
Main Authors:	Shuo-Fu Chen, Liang-Yun Wang, Yi-Sian Lin, Cho-Yi Chen
Format:	Article
Language:	English
Published:	BMC 2025-01-01
Series:	Journal of Ovarian Research
Online Access:	https://doi.org/10.1186/s13048-025-01605-6
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Novel protein-based prognostic signature linked to immunotherapeutic efficiency in ovarian cancer
by: Shuo-Fu Chen, et al.
Published: (2024-09-01)

RBM47 is a novel immunotherapeutic target and prognostic biomarker in gliomas
by: Wei Wei, et al.
Published: (2025-01-01)

Pan-Cancer Analysis of the Prognostic and Immunotherapeutic Value of PDGFB
by: Bai Y, et al.
Published: (2025-01-01)

A novel necroptosis-related gene signature predicts the prognosis and immunotherapeutic response in breast cancer through immune infiltration
by: Dezhi Lu, et al.
Published: (2025-01-01)

Novel Immunotherapeutic Approaches for Neuroblastoma and Malignant Melanoma
by: Fabio Morandi, et al.
Published: (2018-01-01)

TLR7: A Key Prognostic Biomarker and Immunotherapeutic Target in Lung Adenocarcinoma
by: Feiming Hu, et al.
Published: (2025-01-01)

Unlocking prognostic potential: A genomic signature of caloric restriction in patients with epithelial ovarian cancer
by: Ori Tal, et al.
Published: (2025-01-01)

Unlocking prognostic potential: A genomic signature of caloric restriction in patients with epithelial ovarian cancer.
by: Ori Tal, et al.
Published: (2025-01-01)

Integration of single-cell transcriptomics and bulk transcriptomics to explore prognostic and immunotherapeutic characteristics of nucleotide metabolism in lung adenocarcinoma
by: Kai Zhang, et al.
Published: (2025-01-01)

Immunotherapeutic Targeting in Autoimmune Diseases
by: Nona Janikashvili, et al.
Published: (2016-01-01)

New Immunotherapeutic Approaches for Glioblastoma
by: Gustavo Ignacio Vázquez Cervantes, et al.
Published: (2021-01-01)

A Novel 8-Gene Prognostic Signature for Survival Prediction of Uveal Melanoma
by: Zhongjun Tang, et al.
Published: (2021-01-01)

Serum NLR combined with CA125 and HE4 improves the diagnostic and prognostic efficiency in patients with ovarian cancer
by: Yun Tian, et al.
Published: (2024-12-01)

Immunotherapeutic Strategies for Alzheimer's Disease Treatment
by: Beka Solomon
Published: (2009-01-01)

Vaccines and Immunotherapeutics for the Treatment of Malignant Disease
by: Joel F. Aldrich, et al.
Published: (2010-01-01)

Cellular heterogeneity and cytokine signatures in acute myeloid leukemia: A novel prognostic model
by: Jinxia Cao, et al.
Published: (2025-02-01)

A novel histone acetylation-associated gene signature with prognostic value in Ewing sarcoma
by: Anshun Wu, et al.
Published: (2024-12-01)

Comprehensive analyses reveal the promising value of gasdermins as prognostic biomarkers and immunotherapeutic targets in head and neck squamous cell carcinoma
by: Huageng Huang, et al.
Published: (2025-01-01)

Current Advances and Future Prospects in Cancer Immunotherapeutics
by: Zeynep DEDE, et al.
Published: (2023-03-01)

Human vaccines and immunotherapeutics: News December 2024
by: Ronald Ellis, et al.
Published: (2025-12-01)

Identification of a Novel Prognostic Lymphangiogenesis-Related Signature Associated with Tumor Immunity for Guiding Therapy in Lung Adenocarcinoma
by: Juan Peng, et al.
Published: (2024-01-01)

ITGA4 as a potential prognostic and immunotherapeutic biomarker in human cancer and its clinical significance in gastric cancer: an integrated analysis and validation
by: Jiaxing Zhang, et al.
Published: (2025-02-01)

Pan-cancer analysis shows that TNFSF4 is a potential prognostic and immunotherapeutic biomarker for multiple cancer types including liver cancer
by: Zhaoda Deng, et al.
Published: (2025-01-01)

Prognostic significance of albumin corrected anion gap in patients with acute pancreatitis: a novel perspective
by: Jianjun Wang, et al.
Published: (2025-01-01)

CLDN4 as a Novel Diagnostic and Prognostic Biomarker and Its Association with Immune Infiltrates in Ovarian Cancer
by: Pan Hu, et al.
Published: (2023-01-01)

Certificateless-based efficient aggregate signature scheme with universal designated verifier
by: Yu-lei ZHANG, et al.
Published: (2015-02-01)

Exosome-Associated Gene Signature for Predicting the Prognosis of Ovarian Cancer Patients
by: Zihan Zhu, et al.
Published: (2023-01-01)

ID-based efficient and proactive threshold proxy signature in the standard model
by: YU Yi-ke1, et al.
Published: (2011-01-01)

Cuproptosis related lncRNA signature as a prognostic and therapeutic biomarker in osteosarcoma immunity
by: Ziwei Gao, et al.
Published: (2025-01-01)

CYFIP2: potential pancreatic cancer biomarker and immunotherapeutic target
by: Cong Xiao, et al.
Published: (2024-12-01)

Establishment of a prognostic signature and immune infiltration characteristics for uterine corpus endometrial carcinoma based on a disulfidptosis/ferroptosis-associated signature
by: Yong Huang, et al.
Published: (2025-01-01)

Cell Differentiation Trajectory Predicts Prognosis and Immunotherapeutic Response in Clear Cell Renal Cell Carcinoma
by: Jin Xu, et al.
Published: (2022-01-01)

A novel machine learning-based immune prognostic signature for improving clinical outcomes and guiding therapy in colorectal cancer: an integrated bioinformatics and experimental study
by: Yuanchun Zhao, et al.
Published: (2025-01-01)

Development and Validation of an Immunotherapy-Related Prognostic Signature Based on Lymph Node Ratio for Gastric Cancer
by: Jianxin Li, et al.
Published: (2023-01-01)

Author Correction: Development and validation of a prognostic signature of breast cancer based on drug absorption, distribution, metabolism and excretion (ADME)-related genes
by: Zhixuan Wu, et al.
Published: (2024-12-01)

Development of a prognostic gene signature and exploration of P4HA1 in the modulation of cuproptosis in colorectal cancer
by: RenJie Jiang, et al.
Published: (2024-12-01)

Disulfidptosis-related gene signatures as prognostic biomarkers and predictors of immunotherapy response in HNSCC
by: Haotian Qin, et al.
Published: (2025-01-01)

A prognostic model of 8-T/B cell receptor-related signatures for hepatocellular carcinoma
by: Xuan Zuo, et al.
Published: (2025-01-01)

The Immunotherapeutic Effect of SIRPα-Silenced DCs against Cervical Cancer
by: Xiaojie Li, et al.
Published: (2020-01-01)

Immunotherapeutic Potential of Lactobacillus Species as Immune Checkpoint Inhibitors in Cancer Immunotherapy
by: Renukadevi J, et al.
Published: (2025-01-01)